|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/0075 | (2013.01) |
| A61K 9/00 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| C07D 471/04 | (2013.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61K 31/185 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/02 | (2018.01) | ||
| A61P 11/06 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/04 | (2018.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61K 9/0078 | (2013.01) |
| (11) | Number of the document | 3256472 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16704896.6 |
| Date of filing the European patent application | 2016-02-10 | |
| (97) | Date of publication of the European application | 2017-12-20 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2016/050313 |
| Date | 2016-02-10 |
| (87) | Number | WO 2016/128742 |
| Date | 2016-08-18 |
| (30) | Number | Date | Country code |
| 201502260 | 2015-02-11 | GB |
| (72) |
SPARGO, Peter Lionel , GB
FRENCH, Edward James , GB
NORTHEN, Julian Scott , GB
MYKYTIUK, John , GB
|
| (73) |
Verona Pharma PLC ,
One Central Square, Cardiff
CF10 1FS,
GB
|
| (54) | SALT OF A PYRIMIDO[6,1-A]ISOQUINOLIN-4-ONE COMPOUND |
| SALT OF A PYRIMIDO[6,1-A]ISOQUINOLIN-4-ONE COMPOUND |